196 related articles for article (PubMed ID: 11060659)
21. Eotaxins. Contributing to the diversity of eosinophil recruitment and activation.
Bandeira-Melo C; Herbst A; Weller PF
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):653-7. PubMed ID: 11415928
[No Abstract] [Full Text] [Related]
22. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
[TBL] [Abstract][Full Text] [Related]
23. Eosinophil chemotaxis assay in nasal polyps by using a novel optical device EZ-TAXIScan: Role of CC-chemokine receptor 3.
Saito H; Honda K; Asaka C; Ueki S; Ishikawa K
Allergol Int; 2016 Jul; 65(3):280-5. PubMed ID: 26874579
[TBL] [Abstract][Full Text] [Related]
24. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics.
Ying S; Meng Q; Zeibecoglou K; Robinson DS; Macfarlane A; Humbert M; Kay AB
J Immunol; 1999 Dec; 163(11):6321-9. PubMed ID: 10570327
[TBL] [Abstract][Full Text] [Related]
25. Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies.
Zhang L; Soares MP; Guan Y; Matheravidathu S; Wnek R; Johnson KE; Meisher A; Iliff SA; Mudgett JS; Springer MS; Daugherty BL
J Biol Chem; 2002 Sep; 277(37):33799-810. PubMed ID: 12101185
[TBL] [Abstract][Full Text] [Related]
26. IL-16 activates plasminogen-plasmin system and promotes human eosinophil migration into extracellular matrix via CCR3-chemokine-mediated signaling and by modulating CD4 eosinophil expression.
Ferland C; Flamand N; Davoine F; Chakir J; Laviolette M
J Immunol; 2004 Oct; 173(7):4417-24. PubMed ID: 15383572
[TBL] [Abstract][Full Text] [Related]
27. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.
Amerio P; Frezzolini A; Feliciani C; Verdolini R; Teofoli P; De Pità O; Puddu P
Curr Drug Targets Inflamm Allergy; 2003 Mar; 2(1):81-94. PubMed ID: 14561178
[TBL] [Abstract][Full Text] [Related]
28. Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma.
Rojas-Ramos E; Avalos AF; Pérez-Fernandez L; Cuevas-Schacht F; Valencia-Maqueda E; Terán LM
Eur Respir J; 2003 Aug; 22(2):310-6. PubMed ID: 12952266
[TBL] [Abstract][Full Text] [Related]
29. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.
Kleinhans M; Tun-Kyi A; Gilliet M; Kadin ME; Dummer R; Burg G; Nestle FO
Blood; 2003 Feb; 101(4):1487-93. PubMed ID: 12393570
[TBL] [Abstract][Full Text] [Related]
30. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.
Forssmann U; Uguccioni M; Loetscher P; Dahinden CA; Langen H; Thelen M; Baggiolini M
J Exp Med; 1997 Jun; 185(12):2171-6. PubMed ID: 9182688
[TBL] [Abstract][Full Text] [Related]
31. A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.
Sabroe I; Peck MJ; Van Keulen BJ; Jorritsma A; Simmons G; Clapham PR; Williams TJ; Pease JE
J Biol Chem; 2000 Aug; 275(34):25985-92. PubMed ID: 10854442
[TBL] [Abstract][Full Text] [Related]
32. n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation.
Forssmann U; Hartung I; Bälder R; Fuchs B; Escher SE; Spodsberg N; Dulkys Y; Walden M; Heitland A; Braun A; Forssmann WG; Elsner J
J Immunol; 2004 Sep; 173(5):3456-66. PubMed ID: 15322211
[TBL] [Abstract][Full Text] [Related]
33. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
[TBL] [Abstract][Full Text] [Related]
34. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
[TBL] [Abstract][Full Text] [Related]
35. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils.
Dulkys Y; Schramm G; Kimmig D; Knöss S; Weyergraf A; Kapp A; Elsner J
J Invest Dermatol; 2001 Apr; 116(4):498-505. PubMed ID: 11286614
[TBL] [Abstract][Full Text] [Related]
36. Cloning, expression, and characterization of the human eosinophil eotaxin receptor.
Daugherty BL; Siciliano SJ; DeMartino JA; Malkowitz L; Sirotina A; Springer MS
J Exp Med; 1996 May; 183(5):2349-54. PubMed ID: 8642344
[TBL] [Abstract][Full Text] [Related]
37. CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships.
Wacker DA; Santella JB; Gardner DS; Varnes JG; Estrella M; DeLucca GV; Ko SS; Tanabe K; Watson PS; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Duncia JV
Bioorg Med Chem Lett; 2002 Jul; 12(13):1785-9. PubMed ID: 12067561
[TBL] [Abstract][Full Text] [Related]
38. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
Elsner J; Escher SE; Forssmann U
Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
[TBL] [Abstract][Full Text] [Related]
39. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment.
Tillie-Leblond I; Hammad H; Desurmont S; Pugin J; Wallaert B; Tonnel AB; Gosset P
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):586-92. PubMed ID: 10934091
[TBL] [Abstract][Full Text] [Related]
40. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Xanthou G; Duchesnes CE; Williams TJ; Pease JE
Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
